{"cluster": 36, "subcluster": 30, "abstract_summ": "Clinical evidence indicates that the fatal outcome observed with severe acute respiratory syndrome\u2010coronavirus\u20102 infection often results from alveolar injury that impedes airway capacity and multi\u2010organ failure\u2014both of which are associated with the hyperproduction of cytokines, also known as a cytokine storm or cytokine release syndrome.Among these cytokines, IL\u20106 plays a key role in cytokine storm and can predict the adverse clinical outcomes and fatality in these patients.Seriously ill patients with coronavirus disease 2019 (COVID\u201019) at risk for death exhibit elevated cytokine and chemokine levels and D\u2010dimer, and they often have comorbidities related to vascular dysfunctions.In examining leukocyte and cytokine activity in COVID\u201019, we focus in particular on how these levels are altered as the disease progresses (neutrophil NETosis, macrophage, T cell response, etc.) and proposed consequences to organ pathology (coagulopathy, etc.).Here we review reports on leukocyte and cytokine data associated with COVID\u201019 disease in 3939 patients in China and describe emerging data on immunopathology.", "title_summ": "Indomethacin and resveratrol as potential treatment adjuncts for SARS\u2010CoV\u20102/COVID\u201019The potential of cannabidiol in the COVID\u201019 pandemic: a hypothesis letterRepositioning PARP inhibitors for SARS\u2010CoV\u20102 infection (COVID\u201019); a new multi\u2010pronged therapy for ARDS?Mechanism of baricitinib supports artificial intelligence\u2010predicted testing in COVID\u201019 patientsCOVID\u201019 hypothesis: Activated protein C for therapy of virus\u2010induced pathologic thromboinflammationCan steroids reverse the severe COVID\u201019 induced \u2018cytokine storm\u2019?Treatment of COVID\u201019 with pentoxifylline: Could it be a potential adjuvant therapy?Cytokine storm and leukocyte changes in mild versus severe SARS\u2010CoV\u20102 infection: Review of 3939 COVID\u201019 patients in China and emerging pathogenesis and therapy conceptsCytokine storm in COVID\u201019 and parthenolide: preclinical evidenceA hypothesized role for dysregulated bradykinin signaling in COVID\u201019 respiratory complicationsCOVID\u201019: lambda interferon against viral load and hyperinflammationStatins: Could an old friend help the fight against COVID\u201019?Baricitinib: A review of pharmacology, safety and emerging clinical experience in COVID\u201019Targeting the NO\u2010cGMP\u2010PDE5 pathway in COVID\u201019 infection", "title_abstract_phrases": "Cytokine storm and leukocyte changes in mild versus severe SARS\u2010CoV\u20102 infection: Review of 3939 COVID\u201019 patients in China and emerging pathogenesis and therapy conceptsClinical evidence indicates that the fatal outcome observed with severe acute respiratory syndrome\u2010coronavirus\u20102 infection often results from alveolar injury that impedes airway capacity and multi\u2010organ failure\u2014both of which are associated with the hyperproduction of cytokines, also known as a cytokine storm or cytokine release syndrome.Because of its broad spectrum of homeostatic effects in preclinical studies, we speculate that 3K3A\u2010APC merits consideration for clinical trial studies in appropriately chosen, seriously ill patients with COVID\u201019.Can steroids reverse the severe COVID\u201019 induced \u2018cytokine storm\u2019?Severe COVID\u201019 is characterized by an excessive pro\u2010inflammatory cytokine storm, resulting in acute lung injury and development of ARDS.Here we review reports on leukocyte and cytokine data associated with COVID\u201019 disease in 3939 patients in China and describe emerging data on immunopathology.Among these cytokines, IL\u20106 plays a key role in cytokine storm and can predict the adverse clinical outcomes and fatality in these patients.In examining leukocyte and cytokine activity in COVID\u201019, we focus in particular on how these levels are altered as the disease progresses (neutrophil NETosis, macrophage, T cell response, etc.) and proposed consequences to organ pathology (coagulopathy, etc.)."}